← Leaderboards
Stacy Michelle Horner
Duke University
$8,997,349
Attributed
$9,664,336
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2014–25$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,664,336 · 8
By mechanism
R01$7,181,752 · 2
R21$2,213,224 · 5
K22$269,360 · 1
Top collaborators
- Hashim M Al-Hashimi2 shared
- Christopher Edward Mason2 shared
- Debra Silver2 shared
Most similar at Duke University
Same institution · by research overlap
- Ravi R. Jhaveri$579,471
- Shelton Stewart Bradrick$696,854
- Rae Jean Elizabeth Proeschold-Bell$1,745,597
- Cynthia A Moylan$5,972,949
- Allison Roder$34,139
Others in their field
Top investigators on “Virus”
- David Heimbrook · Leidos Biomedical Research, Inc.$512,873,478
- Lawrence Corey · Fred Hutchinson Cancer Center$392,679,667
- Barton F Haynes · Duke University$328,711,626
- Dennis R. Burton · Scripps Research Institute$276,624,892
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$274,342,142
- Richard Webby · St. Jude Children'S Research Hospital$265,067,789
Research focus
VirusRna VirusesPathway InteractionsMolecularVirus ReplicationVirus DiseasesPublic HealthInfectionViralMediatingProteinsViral RnaFlavivirusDesignAntiviral TherapyRegulationMortalityInnovationBaseMorbidity - Disease RateCellsProductionSiteDengue Virus
Grant awards (26)
Defining the role of the RNA modification N6-methyladenosine during Flaviviridae virus infection$583,567
R01 · FY2025 · AI · contact PI
Regulation of RIG-I signaling and viral immune evasion by ufmylation$448,679
R01 · FY2025 · AI · contact PI
Defining the role of the RNA modification N6-methyladenosine during Flaviviridae virus infection$601,615
R01 · FY2024 · AI · contact PI
Regulation of RIG-I signaling and viral immune evasion by ufmylation$448,679
R01 · FY2024 · AI · contact PI
Defining the role of the RNA modification N6-methyladenosine during Flaviviridae virus infection$601,533
R01 · FY2023 · AI · contact PI
Regulation of RIG-I signaling and viral immune evasion by ufmylation$456,729
R01 · FY2023 · AI · contact PI
Defining the role of the RNA modification N6-methyladenosine during Flaviviridae virus infection$616,561
R01 · FY2022 · AI · contact PI
Regulation of RIG-I signaling and viral immune evasion by ufmylation$456,729
R01 · FY2022 · AI · contact PI
Regulation of RIG-I signaling and viral immune evasion by ufmylation$461,559
R01 · FY2021 · AI · contact PI
Targeting Regulatory RNA elements in the Zika Virus$193,566
R21 · FY2021 · AI
Defining the role of the RNA modification N6-methyladenosine in the hepatitis C virus lifecycle$494,822
R01 · FY2020 · AI · contact PI
Targeting Regulatory RNA elements in the Zika Virus$234,095
R21 · FY2020 · AI
Defining a novel function for the post-translational modification ufmylation in the antiviral innate immune response$201,250
R21 · FY2020 · AI · contact PI
Defining the role of the RNA modification N6-methyladenosine in the hepatitis C virus lifecycle$494,822
R01 · FY2019 · AI · contact PI
Defining a novel function for the post-translational modification ufmylation in the antiviral innate immune response$240,750
R21 · FY2019 · AI · contact PI
Defining the role of the RNA modification N6-methyladenosine in the hepatitis C virus lifecycle$489,059
R01 · FY2018 · AI · contact PI
Mapping the RNA modification N6-methyladenosine during Zika virus infection$205,313
R21 · FY2018 · AI
Defining the role of the RNA modification N6-methyladenosine in the hepatitis C virus lifecycle$509,609
R01 · FY2017 · AI · contact PI
Mapping the RNA modification N6-methyladenosine during Zika virus infection$263,750
R21 · FY2017 · AI
Zika virus infection of neural stem cells to model pathogen-induced microcephaly$238,500
R21 · FY2017 · NS
Defining novel Riplet-activated antiviral innate immune signaling pathways$198,750
R21 · FY2017 · AI · contact PI
Defining the role of the RNA modification N6-methyladenosine in the hepatitis C virus lifecycle$517,789
R01 · FY2016 · AI · contact PI
Defining novel Riplet-activated antiviral innate immune signaling pathways$238,500
R21 · FY2016 · AI · contact PI
Zika virus infection of neural stem cells to model pathogen-induced microcephaly$198,750
R21 · FY2016 · NS
Innate immune regulation during hepatitis C virus infection$108,000
K22 · FY2015 · AI · contact PI
Innate immune regulation during hepatitis C virus infection$161,360
K22 · FY2014 · AI · contact PI